Delivery Order SPE2DB22D2005-SPE2DB25FJTQ2
- Not listed
- The Defense Logistics Agency awarded a $2,522.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for one package of Gvoke HypoGel 1 mg/0.2 mL auto-injector. The order is set to be completed by August 18, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a small-value transaction within the company's broader federal pharmaceutical supply portfolio. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Gvoke HypoGel auto-injector pens (2-pack, 1 mg/0.2 mL formulation) with a ceiling value of $3,957.93. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, representing a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Gvoke HypoGlucagon (1-pack, 1 mg/0.2 mL) under a firm fixed-price contract valued at $2,043.63. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery/Indefinite Quantity (IDIQ) prime vendor agreement with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The award was made...
- The Defense Logistics Agency awarded a delivery order valued at $5,028.47 to AmerisourceBergen Drug Corp for the supply of Gvoke HypoPen 2-pack auto-injectors (0.5mg/0.1ml) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-competitive delivery order represents a firm fixed price transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The product is a glucagon emergency injection device used for treating severe...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL dosage). This is a firm fixed-price delivery order with a ceiling value of $10,843.19 and an ultimate completion date of August 26, 2025. The award was competitively procured with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $3,345.20 to AmerisourceBergen Drug Corp for GVOKE HypoGen 2-pack auto-injectors (1 mg/0.2 mL) on June 2, 2025, with an ultimate completion date of June 3, 2025. This non-competitive delivery order is priced on a firm fixed price basis and will be performed at the contractor's location in Conshohocken, Pennsylvania. GVOKE is a glucagon injection used for emergency treatment of severe hypoglycemia in diabetic patients, representing...
- The Defense Logistics Agency awarded a delivery order valued at $9,523.55 to AmerisourceBergen Drug Corp for the supply of Gvoke HypoGen 2-pack auto-injectors (1 mg/0.2 mL) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within...
- The Defense Logistics Agency awarded a $21,248.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GVOKE HypoGen 2-pack auto-injectors (1 mg/0.2 ml), with an ultimate completion date of September 5, 2025. This non-set-aside competitive award leverages AmerisourceBergen's comprehensive indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product delivery will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of GVOKE HypoGel auto-injectors (2-pack, 1 mg/0.2 ml dosage) with a ceiling value of $1,018.78. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order valued at $1,012.14 to AmerisourceBergen Drug Corp for GVOKE 1 MG/0.2 ML emergency glucagon kits on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJTQ2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Gvoke HypoGel 2-pack 1 mg/0.2 ml auto-injectors, a glucagon emergency treatment product used for severe hypoglycemia. The contract is valued at $3,567.70 and represents a firm fixed-price delivery order with a completion date of September 26, 2025. This award is non-set-aside and was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills federal medical procurement requirements through open competition, demonstrating capability across diverse therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/25/25 |